Multiple heparanases are expressed in polymorphonuclear cells

Journal of Surgical Research

Volumn 103, Issue 1, 2002, Pages 100-108

  Kosir, Mary Ann ^a,b,c   Foley Loudon, Patricia A ^b   Finkenauer, Raphaela ^b   Tennenberg, Steven D ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c KARMANOS CANCER INSTITUTE   (United States)

Author keywords

(CTAP III); Connective tissue activating peptide III; Heparan sulfate; Heparanase; hpa; Neutrophils; Polymorphonuclear cells

Indexed keywords

ANTIBODY; CONNECTIVE TISSUE ACTIVATING PEPTIDE; ENZYME; HEPARAN SULFATE; HEPARANASE; HEPARANASE 1; MESSENGER RNA; PEPTIDE; RNA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL ASSAY; CELL ISOLATION; CELL LINE; CELL LYSATE; CHROMATOGRAPHY; ENZYME ACTIVITY; ENZYME ANALYSIS; GENBANK; GENE EXPRESSION; MOLECULAR WEIGHT; NEUTROPHIL; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 0036354964     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.2001.6337     Document Type: Article

References (33)

1. Disruption of the subendothelial basement membrane during neutrophil diapedesis in an in vitro construct of a blood vessel wall
2. Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes
3. Selective inhibition of neutrophil activation by the subendothelial extracellular matrix: Possible role in protection of the vessel wall during diapedesis
4. 2- and COOH-terminal truncations of murine granulocyte chemotactic protein-2 augment the in vitro and in vivo neutrophil chemotactic potency
5. Extracellular matrix moieties, cytokines, and enzymes: Dynamic effects on immune cell behavior and inflammation
6. Proteoglycans: Many forms and many functions
7. Supramolecular organization of extracellular matrix glycosaminoglycans, in vitro and in the tissues
8. Biosynthesis and regulation of expression of proteoglycans
9. Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species
10. Degradation of basement membrane by prostate tumor heparanase
11. Subcellular localization of heparanase in human neutrophils
12. Major co-localization of the extracellular-matrix degradative enzymes heparanase and gelatinase in tertiary granules of human neutrophils
13. A cellulose-binding domain-fused recombinant human T cell connective tissue-activating peptide-III manifests heparanase activity
14. CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes
15. Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis
16. Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis
17. Cloning and functional expression of a human heparanase gene
18. Human heparanase. Purification, characterization, cloning and expression
19. Evidence that platelet and tumour heparanases are similar enzymes
20. Cloning and expression profiling of Hpa2, a novel mammalian heparanase family member
21. Oxidative priming of neutrophils by interferon-gamma
22. Quantitation of mRNA by the polymerase chain reaction
23. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization
24. Processing of the human heparanase precursor and evidence that the active enzyme is a heterodimer
25. Novel C-terminally truncated isoforms of the CXC chemokine betathromboglobulin and their impact on neutrophil functions
26. Leukocyte-derived growth factor links the PDGF and CXC chemokine families of peptides
27. Heparanase activity expressed by platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix
28. Heparanases and tumor metastasis
29. Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: Relationship to tumor cell metastasis
30. Connective tissue activation. XXXIV: Effects of proteolytic processing on the biologic activities of CTAP-III
31. Connective tissue activation. XV. Stimulation of glycosaminoglycan and DNA synthesis by a polymorphonuclear leukocyte factor
32. Connective tissue activation. XXXVI. The origin, variety, distribution, and biologic fate of connective tissue activating peptide-III isoforms: Characteristics in patients with rheumatic, renal, and arterial disease
33. Down-regulation of neutrophil functions by the ELR(+) CXC chemokine platelet basic protein